Trials / Completed
CompletedNCT01544296
A Comparative Study of KHK6188
Phase II Study of KHK6188 (A Placebo-controlled, Double Blind, Crossover Study of KHK6188 in Postherpetic Neuralgia)
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 42 (estimated)
- Sponsor
- Kyowa Kirin Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
This is a placebo-controlled, double blind, crossover study to evaluate the efficacy and safety of KHK6188 in postherpetic neuralgia when administered orally for 2 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | KHK6188 | |
| DRUG | Placebo |
Timeline
- Start date
- 2012-02-01
- Primary completion
- 2013-06-01
- Completion
- 2013-06-01
- First posted
- 2012-03-05
- Last updated
- 2013-10-10
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT01544296. Inclusion in this directory is not an endorsement.